Charts IntelGenx Technologies Corp.

Equities

Delayed OTC Markets Other stock markets 09:30:00 2024-05-01 EDT			5-day change	1st Jan Change
0.1772 ^USD	+9.30%		+8.11%	+28.31%

04-08	Intelgenx Announces First Parkinson?S Disease Patients Dosed with Montelukast Versafilm® in Phase 2 ?Montpark? Clinical Trial	CI
04-05	IntelGenx Updates Status of Buprenorphine Buccal Film ANDA	MT

ProRealTime Chart